Statin drug: New cancer alert
A new drugs alert has gone out this week, warning heart patients that a statin drug for lowering cholesterol may cause cancer.
America’s drug regulator, the Food and Drug Administration (FDA), issued the warning yesterday (September 10) after reviewing the findings of a study into Vytorin, a combination of the two statin drugs simvastatin and ezetimibe.
The researchers have found that many more Vytorin patients developed different cancers, including skin cancer, than those given a placebo, during the five years of the trial.
The FDA points out that the cancer risk has been discovered only in a trial known as SEAS (Simvastatin and Ezetimibe in Aortic Stenosis), while other trials into Vytorin haven’t found any risk.
(Source: FDA website).